Dihydrotestosterone promotes kidney cancer cell proliferation by activating the STAT5 pathway via androgen and glucocorticoid receptors.
Pak, Sahyun
Dihydrotestosterone promotes kidney cancer cell proliferation by activating the STAT5 pathway via androgen and glucocorticoid receptors. [electronic resource] - Journal of cancer research and clinical oncology Sep 2019 - 2293-2301 p. digital
Publication Type: Journal Article
1432-1335
10.1007/s00432-019-02993-1 doi
Androgen Receptor Antagonists--pharmacology
Carcinoma, Renal Cell--genetics
Cell Line, Tumor
Cell Proliferation--drug effects
Dihydrotestosterone--pharmacology
Gene Expression Regulation, Neoplastic--drug effects
Humans
Kidney Neoplasms--genetics
Receptors, Androgen--physiology
Receptors, Glucocorticoid--physiology
STAT5 Transcription Factor--genetics
Signal Transduction--drug effects
Tumor Suppressor Proteins--genetics
Dihydrotestosterone promotes kidney cancer cell proliferation by activating the STAT5 pathway via androgen and glucocorticoid receptors. [electronic resource] - Journal of cancer research and clinical oncology Sep 2019 - 2293-2301 p. digital
Publication Type: Journal Article
1432-1335
10.1007/s00432-019-02993-1 doi
Androgen Receptor Antagonists--pharmacology
Carcinoma, Renal Cell--genetics
Cell Line, Tumor
Cell Proliferation--drug effects
Dihydrotestosterone--pharmacology
Gene Expression Regulation, Neoplastic--drug effects
Humans
Kidney Neoplasms--genetics
Receptors, Androgen--physiology
Receptors, Glucocorticoid--physiology
STAT5 Transcription Factor--genetics
Signal Transduction--drug effects
Tumor Suppressor Proteins--genetics